Homatropine Ophthalmic Solution

Name: Homatropine Ophthalmic Solution

Pregnancy section

Pregnancy Category C. Animal reproduction studies have not been conducted with homatropine hydrobromine. It is also not known whether homatropine hydrobromide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Homamtropine hydrobromide should be given to a pregnant woman ony if clearly needed.

Nursing mothers section

It is not known whether this drug is excreted in human milk. Because many drgs are excreted in human milk,
caution should be exercised when homatropine hydrobromide is administered to a nursing woman.

Pediatric use section

Homatropine should not be used during the first three months of life due to a possible association between the
cycloplegia produced and the development of amblyopia.

Adverse reactions section

Transient symptoms of stinging and burning may occur. Prolonged use may produce local irritation characterized by follicular conjunctivitis, vascular congestion, edema, exudates, and an eczematoid dermatitis. Thirst dryness of mouth, eye irritation not present before therapy, or increased sensitivity of eyes to light may occur.
To report SUSPECTED ADVERSE REACTIONS, contact Altaire Pharmaceuticals, Inc. at (631)-722-5988.

Storage and handling section

Store at 15°-30°C (59°-86°F).

How supplied section

5 mL size in a white plastic bottle.

(web3)